Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

391 ARTÍCULOS , VIENDO DEL 166 AL 180

A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease

Corcos DM, Robichaud JA, David FJ, Leurgans SE, Vaillancourt DE, Poon C, Rafferty MR, Kohrt WM, Comella CL.

Mov Disord. 2013 Aug;28(9):1230-40. doi: 10.1002/mds.25380. Epub 2013 Mar 27.

Mesenchymal stem cells and neuroregeneration in Parkinson's disease

Glavaski-Joksimovic A, Bohn MC.

Exp Neurol. 2013 Sep;247:25-38. doi: 10.1016/j.expneurol.2013.03.016. Epub 2013 Mar 28.

Pharmacologic treatment of anxiety disorders in Parkinson disease

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L.

Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29.

[Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]

García-Gómez FJ, García-Solís D, Luis-Simón FJ, Marín-Oyaga VA, Carrillo F, Mir P, Vázquez-Albertino RJ.

Rev Esp Med Nucl Imagen Mol. 2013 Nov-Dec;32(6):350-6. doi: 10.1016/j.remn.2013.02.009. Epub 2013 Apr 6.

Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease

Borah A, Paul R, Mazumder MK, Bhattacharjee N.

Neurosci Bull. 2013 Oct;29(5):655-60. doi: 10.1007/s12264-013-1330-2. Epub 2013 Apr 10.

A neuroprosthesis for tremor management through the control of muscle co-contraction

Gallego JÁ, Rocon E, Belda-Lois JM, Pons JL.

J Neuroeng Rehabil. 2013 Apr 15;10:36. doi: 10.1186/1743-0003-10-36.

The role of the cerebellum in the pathophysiology of Parkinson's disease

Lewis MM, Galley S, Johnson S, Stevenson J, Huang X, McKeown MJ.

Can J Neurol Sci. 2013 May;40(3):299-306. doi: 10.1017/s0317167100014232.

The heterogeneity of cognitive symptoms in Parkinson's disease: a meta-analysis

Tremblay C, Achim AM, Macoir J, Monetta L.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1265-72. doi: 10.1136/jnnp-2013-305021. Epub 2013 Apr 20.

Head injury and risk of Parkinson disease: a systematic review and meta-analysis

Jafari S, Etminan M, Aminzadeh F, Samii A.

Mov Disord. 2013 Aug;28(9):1222-9. doi: 10.1002/mds.25458. Epub 2013 Apr 22.

Effect of expectancy and personality on cortical excitability in Parkinson's disease

Lou JS, Dimitrova DM, Hammerschlag R, Nutt J, Hunt EA, Eaton RW, Johnson SC, Davis MD, Arnold GC, Andrea SB, Oken BS.

Mov Disord. 2013 Aug;28(9):1257-62. doi: 10.1002/mds.25471. Epub 2013 Apr 29.

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Subramaniam SR, Chesselet MF.

Prog Neurobiol. 2013 Jul-Aug;106-107:17-32. doi: 10.1016/j.pneurobio.2013.04.004. Epub 2013 Apr 30.

Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease

Moro A, Munhoz RP, Moscovich M, Arruda WO, Teive HA.

Parkinsonism Relat Disord. 2013 Aug;19(8):751-4. doi: 10.1016/j.parkreldis.2013.04.021. Epub 2013 May 14.

Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

JAMA Neurol. 2013 Jul;70(7):859-66. doi: 10.1001/jamaneurol.2013.114.

Parkinson disease and exercise

Earhart GM, Falvo MJ.

Compr Physiol. 2013 Apr;3(2):833-48. doi: 10.1002/cphy.c100047.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias